CoChat

Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models of Pneumocystis carinii

Open access
Powles, Mary Ann, Liberator, Paul, Anderson, Jennifer, Karkhanis, Yashwant, Dropinski, James F., Bouffard, F. Aileen, Balkovec, James M., Fujioka, Hisashi, Aikawa, Masamichi, McFadden, Diane, Schmatz, Dennis · 1998 · Antimicrobial Agents and Chemotherapy
Cited by 127

The DOI matches its Crossref record.

Abstract

In addition to its potent efficacy in animal models against Candida sp., Aspergillus fumigatus , and Histoplasma capsulatum , the clinical candidate pneumocandin MK-991 (formerly L-743,872) was also extremely potent against Pneumocystis carinii in models of immune-compromised animals. MK-991 was approximately 14 times more potent than the original natural product lead, pneumocandin B 0 . The 90% effective dose (ED 90 ) of MK-991 for cyst clearance in the rat model for pneumocystis was 0.011 mg/kg of body weight when delivered parenterally for 4 days twice a day (b.i.d.). In a mouse model, under the same experimental parameters, the ED 90 was 0.02 mg/kg. MK-991 was also effective orally, with an ED 90 for cyst clearance of 2.2 mg/kg against acute infection in rats (b.i.d. for 4 days). Complete prevention of P. carinii development was achieved in immunocompromised mice at a daily oral dose of 2.25 mg/kg. As reported previously for other pneumocandins and echinocandins, MK-991 selectively prevented the development of P. carinii cysts. When used as a prophylactic agent, neither stage of the organism appeared in the lungs of animals. In response to an acute infection, cysts were eliminated rapidly, while trophozoite forms persisted. Despite good efficacy as an oral agent in murine models, the low oral absorption of this class may limit the use of MK-991 to parenteral therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.42.8.1985

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 127

Metadata

Authors
Powles, M. A., Liberator, P., Anderson, J., Karkhanis, Y., Dropinski, J. F., Bouffard, F. A., Balkovec, J. M., Fujioka, H., Aikawa, M., McFadden, D., & Schmatz, D.
Venue
Antimicrobial Agents and Chemotherapy
Published
1998-08
Volume
42
Issue
8
Pages
1985-1989
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W1911541991
Cited by
127
References
0
FWCI
7.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models of Pneumocystis carinii. https://app.cochat.ai/papers/10.1128/aac.42.8.1985
The paper
Powles, M. A., Liberator, P., Anderson, J., Karkhanis, Y., Dropinski, J. F., Bouffard, F. A., Balkovec, J. M., Fujioka, H., Aikawa, M., McFadden, D., & Schmatz, D. (1998). Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models of Pneumocystis carinii. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.42.8.1985

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.